Brief: Ovid Therapeutics Appoints Pioneering Industry Leader Dr. Stelios Papadopoulos To Board Of Directors
03/03/2025 14:18
March 3 (Reuters) - Ovid Therapeutics Inc OVID.O: OVID THERAPEUTICS APPOINTS PIONEERING INDUSTRY LEADER DR. STELIOS PAPADOPOULOS TO BOARD OF DIRECTORS Source text: ID:nGNX2hLy66 Further company coverage: OVID.O (Reuters.Briefs@thomsonreuters.com)
Recent news on Ovid Therapeutics
See all newsOvid Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary
Ovid Therapeutics Q2 revenue beats estimates
Brief: Ovid Therapeutics Q2 EPS USD -0.08
Ovid Therapeutics Inc. expected to post a loss of 11 cents a share - Earnings Preview
Brief: Ovid Therapeutics Appoints Leading Physician-Scientist And Biotech Innovator Anna Greka, M.D., Ph.D., To Board Of Directors